Clouston Syndrome
Symptoms, Doctors, Treatments, Advances & More

Learn About Clouston Syndrome

What is the definition of Clouston Syndrome?

Clouston syndrome is a form of ectodermal dysplasia, a group of about 150 conditions characterized by abnormal development of some or all of the ectodermal structures, which include the skin, hair, nails, teeth, and sweat glands. Specifically, Clouston syndrome is characterized by abnormalities of the hair, nails, and skin, with the teeth and sweat glands being unaffected.

What are the causes of Clouston Syndrome?

Clouston syndrome is caused by mutations in the GJB6 gene. This gene provides instructions for making a protein called gap junction beta 6, more commonly known as connexin 30. Connexin 30 is a member of the connexin protein family. Connexin proteins form channels called gap junctions, which permit the transport of nutrients, charged atoms (ions), and signaling molecules between neighboring cells. The size of the gap junction and the types of particles that move through it are determined by the particular connexin proteins that make up the channel. Gap junctions made with connexin 30 transport potassium ions and certain small molecules.

How prevalent is Clouston Syndrome?

The prevalence of Clouston syndrome is unknown. Cases have been reported in many populations; the disorder is especially common among people of French-Canadian descent.

Is Clouston Syndrome an inherited disorder?

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Who are the top Clouston Syndrome Local Doctors?
Elite in Clouston Syndrome
Elite in Clouston Syndrome

Office

1701 Divisadero St # 340, 
San Francisco, CA 
Languages Spoken:
English

Ilona Frieden is a Pediatrics provider in San Francisco, California. Dr. Frieden is rated as an Elite provider by MediFind in the treatment of Clouston Syndrome. Her top areas of expertise are PHACE Syndrome, Hemangioma, Clouston Syndrome, and Ectodermal Dysplasias.

Elite in Clouston Syndrome
Elite in Clouston Syndrome
Erlangen, BY, DE 

Holm Schneider practices in Erlangen, Germany. Schneider is rated as an Elite expert by MediFind in the treatment of Clouston Syndrome. Their top areas of expertise are Hypohidrotic Ectodermal Dysplasia, Clouston Syndrome, Aplasia Cutis Congenita, and Ectodermal Dysplasias.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Clouston Syndrome
Pediatrics
Elite in Clouston Syndrome
Pediatrics

Children's Hospital Primary Care Center (CHPCC)

300 Longwood Ave, 
Boston, MA 
Languages Spoken:
English

Eli Sprecher is a Pediatrics provider in Boston, Massachusetts. Dr. Sprecher is rated as an Elite provider by MediFind in the treatment of Clouston Syndrome. His top areas of expertise are Ectodermal Dysplasias, Clouston Syndrome, Aplasia Cutis Congenita, and Naegeli-Franceschetti-Jadassohn Syndrome.

What are the latest Clouston Syndrome Clinical Trials?
National Cohort for Evaluation of the Burden of Rare Skin Diseases

Summary: The goal of this observational study is to conduct a prospective assessment of the individual Burden of 9 rare skin diseases to assess disability in the broadest sense of the term (psychological, social, economic and physical) for patients and/or families. Two types of indicators will be used to reach this objective : 1. an individual burden score calculated based on a burden questionnaire created...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Familial Investigations of Childhood Cancer Predisposition

Summary: NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may receive results many years from the time they enroll. If you are interested in clinical testing please consider seeing a local genetic counselor or other genetics professional. If you have already had clinical genetic testing and meet eligibility...

Who are the sources who wrote this article ?

Published Date: March 01, 2014
Published By: National Institutes of Health